Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data

被引:0
作者
Dustin J. Little
Matthew Arnold
Katarina Hedman
Ping Sun
Syed Asif Haque
Glen James
机构
[1] Late Cardiovascular,Real World Data Science
[2] Renal,Global Patient Safety BioPharma, BioPharmaceuticals Medical
[3] Metabolism,Cardiovascular, Renal, Metabolism Epidemiology, BioPharmaceuticals Medical
[4] BioPharmaceuticals R&D,undefined
[5] AstraZeneca,undefined
[6] Real World Data Science,undefined
[7] BioPharmaceuticals Medical,undefined
[8] AstraZeneca,undefined
[9] Biometrics CVRM,undefined
[10] BioPharmaceuticals R&D,undefined
[11] AstraZeneca,undefined
[12] Oncology Business Unit,undefined
[13] AstraZeneca,undefined
[14] AstraZeneca,undefined
[15] AstraZeneca,undefined
[16] Present Address: Integrated Evidence Generation & Business Innovation,undefined
来源
BMC Nephrology | / 24卷
关键词
Chronic kidney disease; Hemodialysis; Hyperkalemia; Pneumonia; Sepsis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 221 条
  • [91] Burr R(undefined)undefined undefined undefined undefined-undefined
  • [92] Piraino B(undefined)undefined undefined undefined undefined-undefined
  • [93] Guo H(undefined)undefined undefined undefined undefined-undefined
  • [94] Liu J(undefined)undefined undefined undefined undefined-undefined
  • [95] Collins AJ(undefined)undefined undefined undefined undefined-undefined
  • [96] Foley RN(undefined)undefined undefined undefined undefined-undefined
  • [97] Watanabe R(undefined)undefined undefined undefined undefined-undefined
  • [98] Hunter RW(undefined)undefined undefined undefined undefined-undefined
  • [99] Bailey MA(undefined)undefined undefined undefined undefined-undefined
  • [100] Adamczak M(undefined)undefined undefined undefined undefined-undefined